Professor Neal is a top urological cancer surgeon with a specialist expertise in prostate cancer. He was awarded the Commander of the Order of the British Empire (CBE) for services to surgery in The Queen’s 2014 New Year’s Honours List and was named as one of the leading UK surgeons in The Times in 2011.
His research focuses on the molecular pathology of prostate cancer, particularly on how the androgen receptor interacts with the prostate cancer genome to identify potential biological targets and to stratify risk. He is one of the Principal Investigators on the CRUK funded prostate cancer component of the International Cancer Genome Consortium (ICGC).
‘I am delighted to have taken up this new position at Oxford where I am intending to help develop translational research into prostate cancer, particularly around the molecular biology of prostate cancer and how this might help to stratify future risk,’ he said. Professor Neal has moved from the University of Cambridge, where he was Foundation Chair of Surgical Oncology and a Senior Group Leader in the Cancer Research UK Cambridge Institute carrying out translational research into prostate cancer. He re-developed the clinical department and ensured its position as the Regional Uro-Oncology Centre. In 2005, he introduced robotic prostatectomy and led the regional service for retro-peritoneal node dissections for testis cancer.
Joining the department on a part-time basis, Professor Neal also holds the post of Senior Vice President of Research in Elsevier where he is helping them develop new informatics solutions for researchers.